Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia

Duc Q. Tran; Craig C. Benson; Judith A. Boice; Meera Chitlur; Amy L. Dunn; Miguel A. Escobar; Kalpna Gupta; Jill M. Johnsen; James Jorgenson; Scott D. Martin; Suzanne Martin; Shannon L. Meeks; Alfredo A. Narvaez; Doris V. Quon; Mark T. Reding; Ulrike M. Reiss; Brittany Savage; Kim Schafer; Bruno Steiner; Courtney Thornburg; Lena M. Volland; Annette von Drygalski

doi:10.1080/17474086.2023.2171981

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia

Duc Q. Tran, Craig C. Benson, Judith A. Boice, Meera Chitlur, Amy L. Dunn, Miguel A. Escobar, Kalpna Gupta, Jill M. Johnsen, James Jorgenson, Scott D. Martin, Suzanne Martin, Shannon L. Meeks, Alfredo A. Narvaez, Doris V. Quon, Mark T. Reding, Ulrike M. Reiss, Brittany Savage, Kim Schafer, Bruno Steiner, Courtney ThornburgLena M. Volland, Annette von Drygalski

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Background: Decades of research have transformed hemophilia from severely limiting children’s lives to a manageable disorder compatible with a full, active life, for many in high-income countries. The direction of future research will determine whether exciting developments truly advance health equity for all people with hemophilia (PWH). National Hemophilia Foundation (NHF) and American Thrombosis and Hemostasis Network conducted extensive inclusive all-stakeholder consultations to identify the priorities of people with inherited bleeding disorders and those who care for them. Research design and methods: Working group (WG) 1 of the NHF State of the Science Research Summit distilled the community-identified priorities for hemophilia A and B into concrete research questions and scored their feasibility, impact, and risk. Results: WG1 defined 63 top priority research questions concerning arthropathy/pain/bone health, inhibitors, diagnostics, gene therapy, the pediatric to adult transition of care, disparities faced by the community, and cardiovascular disease. This research has the potential to empower PWH to thrive despite lifelong comorbidities and achieve new standards of wellbeing, including psychosocial. Conclusions: Collaborative research and care delivery will be key to capitalizing on current and horizon treatments and harnessing technical advances to improve diagnostics and testing, to advance health equity for all PWH.

Original language	English (US)
Pages (from-to)	19-37
Number of pages	19
Journal	Expert Review of Hematology
Volume	16
Issue number	sup1
DOIs	https://doi.org/10.1080/17474086.2023.2171981
State	Published - 2023

Bibliographical note

Funding Information:
The entire State of the Science Research Summit and this manuscript were funded by National Hemophilia Foundation. Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R13HL158209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Executive Committee of the National Hemophilia Foundation (NHF) National Research Blueprint initiative were actively engaged in the conception, design, preparation, and oversight of each of the State of the Science manuscripts in this supplement. Maria E. Santaella actively engaged with the lived experience expert (LEE) WG members throughout the process, empowering their inclusion and participation. The Executive Committee consisted of: Kevin Mills, Michael Recht, Michelle L. Witkop, Maria E. Santaella, Donna DiMichele, Keri L. Norris, Esmeralda Vázquez and Brett Spitale. The authors thank Kevin Mills, PhD for his review of the manuscript. Fiona Robinson, PhD provided professional medical writing support during manuscript development; medical illustrations were created by Matt Evans; both paid by NHF.

Publisher Copyright:
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Keywords

Community
National Hemophilia Foundation
hemophilia
inherited bleeding disorders
patient-centered
research

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1080/17474086.2023.2171981

Find It

Find It at U of M Libraries

Cite this

Tran, D. Q., Benson, C. C., Boice, J. A., Chitlur, M., Dunn, A. L., Escobar, M. A., Gupta, K., Johnsen, J. M., Jorgenson, J., Martin, S. D., Martin, S., Meeks, S. L., Narvaez, A. A., Quon, D. V., Reding, M. T., Reiss, U. M., Savage, B., Schafer, K., Steiner, B., ... von Drygalski, A. (2023). Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. Expert Review of Hematology, 16(sup1), 19-37. https://doi.org/10.1080/17474086.2023.2171981

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. / Tran, Duc Q.; Benson, Craig C.; Boice, Judith A. et al.
In: Expert Review of Hematology, Vol. 16, No. sup1, 2023, p. 19-37.

Research output: Contribution to journal › Article › peer-review

Tran, DQ, Benson, CC, Boice, JA, Chitlur, M, Dunn, AL, Escobar, MA, Gupta, K, Johnsen, JM, Jorgenson, J, Martin, SD, Martin, S, Meeks, SL, Narvaez, AA, Quon, DV, Reding, MT, Reiss, UM, Savage, B, Schafer, K, Steiner, B, Thornburg, C, Volland, LM & von Drygalski, A 2023, 'Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia', Expert Review of Hematology, vol. 16, no. sup1, pp. 19-37. https://doi.org/10.1080/17474086.2023.2171981

@article{48670c11ec3849188574b6910869f9f7,

title = "Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia",

abstract = "Background: Decades of research have transformed hemophilia from severely limiting children{\textquoteright}s lives to a manageable disorder compatible with a full, active life, for many in high-income countries. The direction of future research will determine whether exciting developments truly advance health equity for all people with hemophilia (PWH). National Hemophilia Foundation (NHF) and American Thrombosis and Hemostasis Network conducted extensive inclusive all-stakeholder consultations to identify the priorities of people with inherited bleeding disorders and those who care for them. Research design and methods: Working group (WG) 1 of the NHF State of the Science Research Summit distilled the community-identified priorities for hemophilia A and B into concrete research questions and scored their feasibility, impact, and risk. Results: WG1 defined 63 top priority research questions concerning arthropathy/pain/bone health, inhibitors, diagnostics, gene therapy, the pediatric to adult transition of care, disparities faced by the community, and cardiovascular disease. This research has the potential to empower PWH to thrive despite lifelong comorbidities and achieve new standards of wellbeing, including psychosocial. Conclusions: Collaborative research and care delivery will be key to capitalizing on current and horizon treatments and harnessing technical advances to improve diagnostics and testing, to advance health equity for all PWH.",

keywords = "Community, National Hemophilia Foundation, hemophilia, inherited bleeding disorders, patient-centered, research",

author = "Tran, {Duc Q.} and Benson, {Craig C.} and Boice, {Judith A.} and Meera Chitlur and Dunn, {Amy L.} and Escobar, {Miguel A.} and Kalpna Gupta and Johnsen, {Jill M.} and James Jorgenson and Martin, {Scott D.} and Suzanne Martin and Meeks, {Shannon L.} and Narvaez, {Alfredo A.} and Quon, {Doris V.} and Reding, {Mark T.} and Reiss, {Ulrike M.} and Brittany Savage and Kim Schafer and Bruno Steiner and Courtney Thornburg and Volland, {Lena M.} and {von Drygalski}, Annette",

note = "Funding Information: The entire State of the Science Research Summit and this manuscript were funded by National Hemophilia Foundation. Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R13HL158209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Executive Committee of the National Hemophilia Foundation (NHF) National Research Blueprint initiative were actively engaged in the conception, design, preparation, and oversight of each of the State of the Science manuscripts in this supplement. Maria E. Santaella actively engaged with the lived experience expert (LEE) WG members throughout the process, empowering their inclusion and participation. The Executive Committee consisted of: Kevin Mills, Michael Recht, Michelle L. Witkop, Maria E. Santaella, Donna DiMichele, Keri L. Norris, Esmeralda V{\'a}zquez and Brett Spitale. The authors thank Kevin Mills, PhD for his review of the manuscript. Fiona Robinson, PhD provided professional medical writing support during manuscript development; medical illustrations were created by Matt Evans; both paid by NHF. Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",

year = "2023",

doi = "10.1080/17474086.2023.2171981",

language = "English (US)",

volume = "16",

pages = "19--37",

journal = "Expert Review of Hematology",

issn = "1747-4086",

publisher = "Expert Reviews Ltd.",

number = "sup1",

}

TY - JOUR

T1 - Building the foundation for a community-generated national research blueprint for inherited bleeding disorders

T2 - research priorities to transform the care of people with hemophilia

AU - Tran, Duc Q.

AU - Benson, Craig C.

AU - Boice, Judith A.

AU - Chitlur, Meera

AU - Dunn, Amy L.

AU - Escobar, Miguel A.

AU - Gupta, Kalpna

AU - Johnsen, Jill M.

AU - Jorgenson, James

AU - Martin, Scott D.

AU - Martin, Suzanne

AU - Meeks, Shannon L.

AU - Narvaez, Alfredo A.

AU - Quon, Doris V.

AU - Reding, Mark T.

AU - Reiss, Ulrike M.

AU - Savage, Brittany

AU - Schafer, Kim

AU - Steiner, Bruno

AU - Thornburg, Courtney

AU - Volland, Lena M.

AU - von Drygalski, Annette

N1 - Funding Information: The entire State of the Science Research Summit and this manuscript were funded by National Hemophilia Foundation. Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R13HL158209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Executive Committee of the National Hemophilia Foundation (NHF) National Research Blueprint initiative were actively engaged in the conception, design, preparation, and oversight of each of the State of the Science manuscripts in this supplement. Maria E. Santaella actively engaged with the lived experience expert (LEE) WG members throughout the process, empowering their inclusion and participation. The Executive Committee consisted of: Kevin Mills, Michael Recht, Michelle L. Witkop, Maria E. Santaella, Donna DiMichele, Keri L. Norris, Esmeralda Vázquez and Brett Spitale. The authors thank Kevin Mills, PhD for his review of the manuscript. Fiona Robinson, PhD provided professional medical writing support during manuscript development; medical illustrations were created by Matt Evans; both paid by NHF. Publisher Copyright: © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

PY - 2023

Y1 - 2023

N2 - Background: Decades of research have transformed hemophilia from severely limiting children’s lives to a manageable disorder compatible with a full, active life, for many in high-income countries. The direction of future research will determine whether exciting developments truly advance health equity for all people with hemophilia (PWH). National Hemophilia Foundation (NHF) and American Thrombosis and Hemostasis Network conducted extensive inclusive all-stakeholder consultations to identify the priorities of people with inherited bleeding disorders and those who care for them. Research design and methods: Working group (WG) 1 of the NHF State of the Science Research Summit distilled the community-identified priorities for hemophilia A and B into concrete research questions and scored their feasibility, impact, and risk. Results: WG1 defined 63 top priority research questions concerning arthropathy/pain/bone health, inhibitors, diagnostics, gene therapy, the pediatric to adult transition of care, disparities faced by the community, and cardiovascular disease. This research has the potential to empower PWH to thrive despite lifelong comorbidities and achieve new standards of wellbeing, including psychosocial. Conclusions: Collaborative research and care delivery will be key to capitalizing on current and horizon treatments and harnessing technical advances to improve diagnostics and testing, to advance health equity for all PWH.

AB - Background: Decades of research have transformed hemophilia from severely limiting children’s lives to a manageable disorder compatible with a full, active life, for many in high-income countries. The direction of future research will determine whether exciting developments truly advance health equity for all people with hemophilia (PWH). National Hemophilia Foundation (NHF) and American Thrombosis and Hemostasis Network conducted extensive inclusive all-stakeholder consultations to identify the priorities of people with inherited bleeding disorders and those who care for them. Research design and methods: Working group (WG) 1 of the NHF State of the Science Research Summit distilled the community-identified priorities for hemophilia A and B into concrete research questions and scored their feasibility, impact, and risk. Results: WG1 defined 63 top priority research questions concerning arthropathy/pain/bone health, inhibitors, diagnostics, gene therapy, the pediatric to adult transition of care, disparities faced by the community, and cardiovascular disease. This research has the potential to empower PWH to thrive despite lifelong comorbidities and achieve new standards of wellbeing, including psychosocial. Conclusions: Collaborative research and care delivery will be key to capitalizing on current and horizon treatments and harnessing technical advances to improve diagnostics and testing, to advance health equity for all PWH.

KW - Community

KW - National Hemophilia Foundation

KW - hemophilia

KW - inherited bleeding disorders

KW - patient-centered

KW - research

UR - http://www.scopus.com/inward/record.url?scp=85150341318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150341318&partnerID=8YFLogxK

U2 - 10.1080/17474086.2023.2171981

DO - 10.1080/17474086.2023.2171981

M3 - Article

C2 - 36920859

AN - SCOPUS:85150341318

SN - 1747-4086

VL - 16

SP - 19

EP - 37

JO - Expert Review of Hematology

JF - Expert Review of Hematology

IS - sup1

ER -

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this